131 Summarized discussion and future perspectives. [33]Xu C, Guo L, Liao Z, Wang Y, Liu X, Zhao S, et al. Clinical and Translational Radiation Oncology Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy. Clin Transl Radiat Oncol 2019;17:17–23. https://doi.org/10.1016/j. ctro.2019.04.016. [34]Lin J Bin, Hung LC, Cheng CY, Chien YA, Lee CH, Huang CC, et al. Prognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapy. Radiat Oncol 2019;14:1–10. https://doi.org/10.1186/s13014-019-1283-3. [35]Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, et al. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer. J Am Coll Cardiol 2019;73:2976–87. https://doi.org/10.1016/j.jacc.2019.03.500. [36]Speirs CK, DeWees TA, Rehman S, Molotievschi A, Velez MA, Mullen D, et al. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer. J Thorac Oncol 2017;12:293–301. https://doi.org/10.1016/j.jtho.2016.09.134. [37]Song J, Verbeeck J, Huang B, Hoaglin DC, Gamalo-Siebers M, Seifu Y, et al. The win odds: statistical inference and regression. J Biopharm Stat 2022;33:140–50. https://doi.org/10.1080/ 10543406.2022.2089156. 8
RkJQdWJsaXNoZXIy MTk4NDMw